Results 51 to 60 of about 781 (182)
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions [PDF]
The current BSC guidance issued by the FDA allows for biowaivers based on conservative criteria. Possible new criteria and class boundaries are proposed for additional biowaivers based on the underlying physiology of the gastrointestinal tract. The proposed changes in new class boundaries for solubility and permeability are as follows: 1.
Polli, James E. +10 more
openaire +3 more sources
INRODUCTION. Biowaiver procedure based on the biopharmaceutics classification system (BCS) is widely used in regulatory practice when assessing the bioequivalence of generic medicinal products (GMPs).
N. J. Dahma +5 more
doaj +1 more source
A biowaiver is accepted by the Brazilian Health Surveillance Agency (ANVISA) for immediate-release solid oral products containing Biopharmaceutics Classification System (BCS) class I drugs showing rapid drug dissolution.
Marcelo Dutra Duque +5 more
doaj +1 more source
Physiologically based absorption modeling to predict the bioequivalence of two apixaban formulations. [PDF]
Abstract The equivalence of absorption rates and extents between generic drugs and their reference formulations is crucial for ensuring therapeutic comparability. Bioequivalence (BE) studies are widely utilized and play a pivotal role in substantiating the approval and promotional efforts for generic drugs.
Luo T +7 more
europepmc +2 more sources
BCS-based biowaivers : risks and opportunities
Bei peroral eingenommenen Arzneimitteln wird das Plasmakonzentrations-Zeit-Profil des aktiven Stoffes im Allgemeinen als Maß für die Wirksamkeit und Sicherheit des Arzneimittels angesehen. Bei Veränderungen an bestehenden Arzneimitteln oder der Entwicklung eines Generikums kann durch Bioäquivalenzstudien an gesunden Probanden untersucht werden, ob das ...
Kubbinga, ME
openaire +5 more sources
Human radiolabeled mass balance studies are crucial for comprehensively characterizing the absorption, distribution, metabolism, and excretion (ADME) of investigational drugs, providing essential data for drug development, regulatory evaluation, and product labeling.
Jason Boer +24 more
wiley +1 more source
Types of Biowaivers: A Discussion
The aim of the present review is to discuss the different types of biowaiver applications. Waiving of In vivo bioequivalence studies is known as biowaiver. Types of biowaiver applications include BCS based biowaiver, well established use application, also known as bibliographical application and Literature based submission.
openaire +1 more source
Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling
ABSTRACT Physiologically based pharmacokinetic (PBPK) modeling is a mechanistic cornerstone of model‐informed drug development (MIDD), providing evidence for regulatory decisions. PBPK models integrate physiological and pharmacological data and have been applied across a plethora of contexts of use, including assessing drug–drug interactions (DDIs ...
Marylore Chenel +6 more
wiley +1 more source
Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Moxifloxacin Hydrochloride
S.2654-2675In this monograph, literature data is reviewed to evaluate the feasibility of waiving in vivo bioequivalence testing and instead applying the Biopharmaceutics Classification System (BCS) based methods to the approval of immediate-release solid
Mehta, M. +12 more
core +1 more source
Scientific Opinion on waiving of the dog studies in the regulatory process of agrochemicals approval
Abstract Commission Regulation (EU) No. 283/2013 sets out the data requirements for pesticide active substances and includes short‐term oral toxicity testing in rodents (90‐day rat study) and non‐rodents (90‐day dog study) to support human health hazard assessment for pesticide active substances in the European Union (EU). However, the relevance of the
EFSA Panel on Plant Protection Products and their Residues (PPR) +20 more
wiley +1 more source

